- Home
- CHNR vs NCNA Comparison
CHNR vs NCNA Comparison
Compare CHNR & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- NCNA
- Stock Information
- Founded
- CHNR N/A
- NCNA 1997
- Country
- CHNR Hong Kong
- NCNA United Kingdom
- Employees
- CHNR N/A
- NCNA N/A
- Industry
- CHNR Precious Metals
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- NCNA Health Care
- Exchange
- CHNR Nasdaq
- NCNA Nasdaq
- Market Cap
- CHNR 4.8M
- NCNA 4.5M
- IPO Year
- CHNR 1995
- NCNA 2017
- Fundamental
- Price
- CHNR $0.51
- NCNA $0.05
- Analyst Decision
- CHNR
- NCNA Buy
- Analyst Count
- CHNR 0
- NCNA 2
- Target Price
- CHNR N/A
- NCNA $25.00
- AVG Volume (30 Days)
- CHNR 9.6K
- NCNA 13.0M
- Earning Date
- CHNR 01-01-0001
- NCNA 05-19-2025
- Dividend Yield
- CHNR N/A
- NCNA N/A
- EPS Growth
- CHNR N/A
- NCNA N/A
- EPS
- CHNR N/A
- NCNA N/A
- Revenue
- CHNR N/A
- NCNA N/A
- Revenue This Year
- CHNR N/A
- NCNA N/A
- Revenue Next Year
- CHNR N/A
- NCNA N/A
- P/E Ratio
- CHNR N/A
- NCNA N/A
- Revenue Growth
- CHNR N/A
- NCNA N/A
- 52 Week Low
- CHNR $0.45
- NCNA $0.10
- 52 Week High
- CHNR $1.13
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- CHNR 48.33
- NCNA 34.84
- Support Level
- CHNR $0.51
- NCNA $0.41
- Resistance Level
- CHNR $0.57
- NCNA $0.42
- Average True Range (ATR)
- CHNR 0.04
- NCNA 0.13
- MACD
- CHNR 0.00
- NCNA -0.06
- Stochastic Oscillator
- CHNR 55.83
- NCNA 0.10
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.